BIOCONTROL TECHNOLOGY, INC.
2275 Swallow Hill Road - Building 2500 - Pittsburgh, PA 15220
(412) 429-0673 Fax: (412) 279-1367
US HOUSE OF REPRESENTATIVES TO INVESTIGATE FDA HANDLING OF BIOCONTROL TECHNOLOGY 510(K) SUMBISSION
Pittsburgh, PA - September 20, 1996 - Biocontrol Technology, Inc. (NASDAQ:BICO) announced today that it has been notified by the US House of Representatives Subcommittee on Oversight and Investigations that a hearing will be held Thursday, September 26, 1996 to examine the manner in which the Food and Drug Adminstration (FDA) handled Biocontrol Technology's 510(k) submission and the February 26, 1996 Advisory Panel Review for its Diasensor 1000(TM) noninvasive glucose sensor for diabetics.
The decision to conduct this hearing, the Company has been informed, was based on investigations conducted by the Subcommittee during the last several months.
The hearing will be held at 10:00 a.m. in Room 2322 of the Rayburn House Office Building in Washington, DC and is open to the public. No further details are known by the Company at this time.
BICO submitted its 510(k) premarket notification for the Diasensor 1000 to the FDA in January 1994.
Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products.
Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.